fda approved glp-1 receptor agonists of GLP-1RAs for the treatment of type 2 diabetes. US Food π¨ PUBLIC HEALTH WARNINGπ¨ HINDI
Description
2020;4(2):e00204
Similarly, interrupted use was associated with increased MACE risk, with IRRs of 1.12 for one year and 1.16 for two years of interruption, with effect sizes differing modestly depending on prior treatment duration
It has not (yet) been approved for weight management
The mean [95% CI] reduction in HbA 1c was 0.7%point [0.51
Analysts project the market could expand fivefold within five years
DelveInsights ' GLP Agonist Pipeline Insight 2024 ' report provides comprehensive global coverage of pipeline GLP agonists in various stages of clinical development, major pharmaceutical companies are working to advance the pipeline space and future growth potential of the GLP agonist pipeline domain
